APEX Labs is a socially focused pharmaceutical company focused on psychedelic drug product to market for patients suffering from Post-Traumatic Disorder (PTSD), depression, addiction and other related mental health conditions. APEX’s Canadian clinical development program is focused on Veterans – groups that are most affected by these disorders. The Company’s lead clinical candidate is a low-dose synthetic psilocybin for the treatment of PTSD. To learn more please visit us at: www.apexlabs.com